The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia

Clinical Infectious Diseases

Volumn 47, Issue 9, 2008, Pages 1171-1175

  Lorente, Leonardo ^a   Lecuona, María ^a   Ramos, María José ^a   Jiménez, Alejandro ^a   Mora, María L ^a   Sierra, Antonio ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MICONAZOLE; RIFAMPICIN;

ADULT; ARTICLE; BACTEREMIA; CANDIDA ALBICANS; CATHETER; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; FEMORAL VEIN; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; JUGULAR VEIN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RIFAMPICIN MICONAZOLE IMPREGNATED CATHETER; RISK REDUCTION; STAPHYLOCOCCUS HOMINIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; COATED MATERIALS, BIOCOMPATIBLE; COHORT STUDIES; FEMALE; FEMORAL VEIN; HUMANS; JUGULAR VEINS; MALE; MICONAZOLE; MIDDLE AGED; RIFAMPIN;

EID: 53349118564     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592253     Document Type: Article

References (17)

1. Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicinim-pregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2007; 59:359-69.
2. Shorr AF, Humphreys CW, Helman DL. New choices for central venous catheters: potential financial implications. Chest 2003; 124:275-84.
3. O'Grady NP, Alexander M, Dellinger EP, et al; Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. Pediatrics 2002; 110:e51.
4. Lorente L, Henry C, Martin MM, Jimenez A, Mora ML. Central venous catheter-related infection in a prospective and observational study of 2595 catheters. Critical Care 2005; 9:R631-5.
5. Lorente L, Jiménez A, Castedo J, et al. Internal jugular venous catheter-related bacteremia according to central and posterior accesses. Intensive Care Medicine 2007; 33:1071-5.
6. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous catheter-related infection. N Engl J Med 1977; 296:1305-9.
7. Mehta C Patel N. LogXact for Windows. In: Cytel Software Corporation, eds. User manual for LogXact for Windows. Cambridge, MA: Cytel Software Corporation, 2000; 123-70.
8. Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 2006; 34:668-75.
9. León C, Ruiz-Santana S, Rello J, et al.; Cabaña Study Group. Benefits of minocycline and rifampin-impregnated central venous catheters: a prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 2004; 30:1891-9.
10. Chatzinikolaou I, Finkel K, Hanna H, et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med 2003; 115:352-7.
11. Yücel N, Lefering R, Maegele M, et al. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial. J Antimicrob Chemother 2004; 54:1109-15.
12. Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001; 22:640-6.
13. Schierholz JM, Fleck C, Beuth J, et al. The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J Antimicrob Chemother 2000; 46:45-50.
14. Sherertz RJ, Carruth WA, Hampton AA, et al. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 1993; 167:98-106.
15. Timsit JF, Sebille V, Farkas JC, et al. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 1996; 276:1416-20.
16. Timsit JF, Bruneel F, Cheval C, et al. Use of tunneled femoral catheters to prevent catheter-related infection: a randomized, controlled trial. Ann Intern Med 1999; 130:729-35.
17. Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med 1998; 26:1452-7.